Globe Life (NYSE:GL) Releases FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Friday morning. The company provided EPS guidance of 15.350-15.650 for the period, compared to the consensus earnings per share estimate of 15.720. Globe Life also updated its FY 2027 guidance to 16.100-17.100 EPS.

Globe Life Price Performance

Shares of NYSE GL traded down $13.16 on Friday, hitting $155.25. The company’s stock had a trading volume of 753,996 shares, compared to its average volume of 543,970. Globe Life has a 12-month low of $127.85 and a 12-month high of $191.55. The company has a market capitalization of $11.93 billion, a price-to-earnings ratio of 10.31 and a beta of 0.44. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a 50 day moving average of $170.48 and a 200-day moving average of $167.25.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share for the quarter, missing analysts’ consensus estimates of $4.90 by ($0.06). Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the business earned $4.81 earnings per share. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, research analysts predict that Globe Life will post 15.70 EPS for the current year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is 8.76%.

Globe Life announced that its Board of Directors has initiated a stock buyback plan on Monday, August 10th that authorizes the company to buy back $2.50 billion in shares. This repurchase authorization authorizes the company to repurchase up to 17.7% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research firms recently commented on GL. UBS Group set a $165.00 price objective on Globe Life in a research report on Friday. JPMorgan Chase & Co. upped their target price on shares of Globe Life from $193.00 to $195.00 and gave the company an “overweight” rating in a report on Thursday, October 15th. TD Cowen reduced their target price on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating on the stock in a report on Friday. Jefferies Financial Group lifted their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. Finally, Piper Sandler lowered shares of Globe Life from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $200.00 to $165.00 in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus target price of $182.60.

Insider Buying and Selling at Globe Life

In related news, EVP Robert Hensley sold 10,000 shares of Globe Life stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the transaction, the executive vice president owned 12,384 shares in the company, valued at approximately $2,106,146.88. The trade was a 44.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO James Darden sold 50,000 shares of the company’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This trade represents a 46.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 143,650 shares of company stock valued at $25,793,717 in the last ninety days. Corporate insiders own 2.11% of the company’s stock.

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: TD Cowen maintained a Buy rating and lowered its price target from $225 to $215, still implying substantial upside from current levels. TD Cowen Globe Life price target update
• Positive Sentiment: Globe Life projected 2027 adjusted EPS of $16.10 to $17.10, with the midpoint modestly above the current consensus estimate, and targeted $850 million to $950 million in parent excess cash flow. Globe Life 2027 earnings and cash flow outlook
• Positive Sentiment: Third-quarter revenue rose 5.5% year over year to approximately $1.60 billion, exceeding analyst expectations, while operating EPS increased slightly from $4.81 to $4.84. Globe Life third-quarter 2026 results
• Neutral Sentiment: For 2027, the EPS guidance range broadly brackets consensus, suggesting expectations remain intact but with a relatively wide outlook range.
• Negative Sentiment: Third-quarter operating EPS of $4.84 missed the approximately $4.90 consensus estimate. Weaker underwriting income and higher expenses offset gains from premiums and investment income. Globe Life third-quarter earnings miss
• Negative Sentiment: Globe Life reduced its 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Losses tied to Evry Health were cited among the factors behind the guidance cut. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded the stock following the quarterly announcement, reinforcing concerns about underwriting performance and near-term earnings. Piper Sandler Globe Life downgrade

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.